Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade
BJU International · 2025
DOI: 10.1111/bju.16624 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJU International, 2025. Verfasst von Frederik F Thomsen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Copenhagen University Hospital - Herlev and Gentofte Hospital, Herlev, Denmark. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objective
To identify predictors of metastases, estimate the proportion of metastatic clear cell renal cell carcinoma (ccRCC) cases according to these predictors, and subsequently create a risk table showing the absolute difference in metastasis proportion for each 10 mm increase in tumour size. Patients and Methods Patients diagnosed with histopathological confirmed ccRCC in 2010–2018 in Denmark identified in the nationwide Danish Multidisciplinary Renal Cancer Group (DaRenCa) Study‐3. Association between diagnostic variables and metastases were assessed with logistic regression analyses. Proportion of cases with metastases were assess based on tumour sizes using a logistic regression model.
Results
The study included 2109 cases with non‐metastatic ccRCC at diagnosis and 450 cases with metastatic ccRCC. Multivariable logistic regression analyses found sex, tumour size and grade were associated with metastatic ccRCC, whereas age was not. The proportion of cases with metastasis increased with larger tumours sizes and higher grade. As an example, the proportion of metastases in female cases with tumour size of 40 mm was 2.9% (95% confidence interval [CI] 1.7–4.8%) in Grade 1 and 16% (95% CI 12–22%) in cases with Grade 4. Comparable numbers in cases with a tumour size of 70 mm were 6.6% (95% CI 4.0–11%) and 31% (95% CI 25–38). The absolute increase in the proportion of cases with metastases with a 10 mm increase in size was
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Copenhagen University Hospital - Herlev and Gentofte Hospital, Herlev, Denmark.
- Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
- Department of Urology, Zealand University Hospital, Roskilde, Denmark.
- Department of Urology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Urology, Gødstrup Hospital, Gødstrup, Denmark.
- Department of Urology, Odense University Hospital, Odense, Denmark.
ORCID-Profile: Marcus Westerberg, Rasmine Bak
Zitieren
APA
Thomsen, F. F., Westerberg, M., Petersson, R. D., Bak, R., Lindholst, J. B., Al-Husseinawi, H., Heeno, E., & Azawi, N. H. (2025). Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade. BJU International. https://doi.org/10.1111/bju.16624
Vancouver
Thomsen FF, Westerberg M, Petersson RD, Bak R, Lindholst JB, Al-Husseinawi H, et al. Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade. BJU International. 2025. doi:10.1111/bju.16624
BibTeX
@article{Thomsen2025,
author = {Thomsen, Frederik F and Westerberg, Marcus and Petersson, Rasmus D and Bak, Rasmine and Lindholst, Julie Bak and Al-Husseinawi, Hayder and Heeno, Emma and Azawi, Nessn H},
title = {Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade},
journal = {BJU International},
year = {2025},
doi = {10.1111/bju.16624}
}
EUVIMED